TY - JOUR
T1 - Patient's experience of psoriatic arthritis
T2 - A conceptual model based on qualitative interviews
AU - Ogdie, Alexis
AU - Michaud, Kaleb
AU - Nowak, Miroslawa
AU - Bruce, Rachel
AU - Cantor, Sarah
AU - Hintzen, Carlijn
AU - Mease, Philip J.
N1 - Funding Information:
Twitter Kaleb Michaud @Dr_K. Acknowledgements The authors wish to thank Evo Alemao for his insights in the design and conduct of the study. Medical writing assistance was provided by M. Casamayor, PhD, of IQVIA, funded by the study sponsors. Contributors AO, KM, MN and PJM conceived and designed the study; RB, SC and CH conducted the literature review, and contributed to the patient interviews and data analyses; and all authors contributed in the writing of the manuscript.
Publisher Copyright:
© 2020 BMJ Publishing Group. All rights reserved.
PY - 2020/10/28
Y1 - 2020/10/28
N2 - Introduction Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory musculoskeletal disorder that manifests as peripheral arthritis, dactylitis, enthesitis and spondylitis. PsA results in significant burden that impacts quality of life of patients. We examined the signs, symptoms and impacts reported by patients with PsA, to characterise the patient experience of PsA and develop a conceptual model representing this patient experience. Methods Semi-structured interviews were conducted with patients with PsA recruited through the FORWARD databank. Spontaneous and probed signs, symptoms and impacts of PsA were assessed. Patients rated the disturbance of these concepts on their lives using a scale from 0 ('does not disturb') to 10 ('greatly disturbs'). Signs, symptoms and impacts reported by >80% of patients with a disturbance rating of ≥5 were defined as salient concepts. Recruitment continued until concept saturation was achieved. Results 19 patients with PsA were interviewed. The interviews elicited 42 symptoms of which 8 had not been identified in a previous literature review encompassing 15 relevant articles. The most salient signs and symptoms elicited in the interviews were joint pain, skin symptoms, stiffness, swollen/inflamed joints and fatigue all with moderate to high disturbance ratings (range: 5.5-7.8). The most salient impacts were sleep disturbance, physical disability, effects on daily activities and feelings of frustration with also moderate to high disturbance ratings (range: 6.1-7.4). Conclusions The interviews highlighted the adverse impact PsA has on the patient's life and may inform on outcome variables or areas suitable to be assessed in PsA studies.
AB - Introduction Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory musculoskeletal disorder that manifests as peripheral arthritis, dactylitis, enthesitis and spondylitis. PsA results in significant burden that impacts quality of life of patients. We examined the signs, symptoms and impacts reported by patients with PsA, to characterise the patient experience of PsA and develop a conceptual model representing this patient experience. Methods Semi-structured interviews were conducted with patients with PsA recruited through the FORWARD databank. Spontaneous and probed signs, symptoms and impacts of PsA were assessed. Patients rated the disturbance of these concepts on their lives using a scale from 0 ('does not disturb') to 10 ('greatly disturbs'). Signs, symptoms and impacts reported by >80% of patients with a disturbance rating of ≥5 were defined as salient concepts. Recruitment continued until concept saturation was achieved. Results 19 patients with PsA were interviewed. The interviews elicited 42 symptoms of which 8 had not been identified in a previous literature review encompassing 15 relevant articles. The most salient signs and symptoms elicited in the interviews were joint pain, skin symptoms, stiffness, swollen/inflamed joints and fatigue all with moderate to high disturbance ratings (range: 5.5-7.8). The most salient impacts were sleep disturbance, physical disability, effects on daily activities and feelings of frustration with also moderate to high disturbance ratings (range: 6.1-7.4). Conclusions The interviews highlighted the adverse impact PsA has on the patient's life and may inform on outcome variables or areas suitable to be assessed in PsA studies.
KW - Arthritis
KW - Patient Reported Outcome Measures
KW - Psoriatic
KW - Qualitative research
UR - http://www.scopus.com/inward/record.url?scp=85094827820&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094827820&partnerID=8YFLogxK
U2 - 10.1136/rmdopen-2020-001321
DO - 10.1136/rmdopen-2020-001321
M3 - Article
C2 - 33115768
AN - SCOPUS:85094827820
SN - 2056-5933
VL - 6
JO - RMD Open
JF - RMD Open
IS - 3
M1 - e001321
ER -